There is a quiet revolution happening in cardiovascular medicine, and it doesn’t involve a new drug, a surgical device, or a ...
In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving =30% weight loss, a level long associated with bariatric surgery ...